Search research articles
Contact Us
Filters
Showing results (31-40 of 66) with videos related to
Page
of 7
Sort By:
Cancer Research
|
May 8, 2013
GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors
Andrea Morandi, Lesley-Ann Martin, Qiong Gao, et al.
Oncotarget
|
August 20, 2016
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells
Luigi Ippolito, Alberto Marini, Lorenzo Cavallini, et al.
Hormones & Cancer
|
March 6, 2014
Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation
Elena Rapizzi, Tonino Ercolino, Rossella Fucci, et al.
Cancer Treatment Reviews
|
May 27, 2022
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside
Icro Meattini, Lorenzo Livi, Nicla Lorito, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
June 22, 2026
Elevated ESR2 and BRCA1 gene expression in adenomyosis associated with endometrial cancer: a pilot study
Francesco La Torre, Eleonora Nardi, Francesca Bonechi, et al.
Cell Death & Disease
|
November 10, 2025
Lead induces cell-autonomous proliferation and metabolic reprogramming of hepatocytes
Marina Serra, Alfredo Smiriglia, Cristina Migliore, et al.
Breast Cancer Research : BCR
|
June 23, 2025
In vivo imaging of the spatial heterogeneity of intratumoral acidosis (pH) as a marker of the metastatic phenotype in breast cancer
Alessia Corrado, Nicla Lorito, Annasofia Anemone, et al.
Molecular Oncology
|
August 6, 2014
Senescent stroma promotes prostate cancer progression: the role of miR-210
Maria Letizia Taddei, Lorenzo Cavallini, Giuseppina Comito, et al.
The Journal of Biological Chemistry
|
April 2, 2011
Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism
Iván Plaza-Menacho, Andrea Morandi, Luca Mologni, et al.
Cancer Research
|
January 23, 2016
miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors
Marina Bacci, Elisa Giannoni, Antony Fearns, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 66) with videos related to
Sort By:
Page
of 7
Cancer Research
|
May 8, 2013
GDNF-RET signaling in ER-positive breast cancers is a key determinant of response and resistance to aromatase inhibitors
Andrea Morandi, Lesley-Ann Martin, Qiong Gao, et al.
Oncotarget
|
August 20, 2016
Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells
Luigi Ippolito, Alberto Marini, Lorenzo Cavallini, et al.
Hormones & Cancer
|
March 6, 2014
Succinate dehydrogenase subunit B mutations modify human neuroblastoma cell metabolism and proliferation
Elena Rapizzi, Tonino Ercolino, Rossella Fucci, et al.
Cancer Treatment Reviews
|
May 27, 2022
Integrating radiation therapy with targeted treatments for breast cancer: From bench to bedside
Icro Meattini, Lorenzo Livi, Nicla Lorito, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology
|
June 22, 2026
Elevated ESR2 and BRCA1 gene expression in adenomyosis associated with endometrial cancer: a pilot study
Francesco La Torre, Eleonora Nardi, Francesca Bonechi, et al.
Cell Death & Disease
|
November 10, 2025
Lead induces cell-autonomous proliferation and metabolic reprogramming of hepatocytes
Marina Serra, Alfredo Smiriglia, Cristina Migliore, et al.
Breast Cancer Research : BCR
|
June 23, 2025
In vivo imaging of the spatial heterogeneity of intratumoral acidosis (pH) as a marker of the metastatic phenotype in breast cancer
Alessia Corrado, Nicla Lorito, Annasofia Anemone, et al.
Molecular Oncology
|
August 6, 2014
Senescent stroma promotes prostate cancer progression: the role of miR-210
Maria Letizia Taddei, Lorenzo Cavallini, Giuseppina Comito, et al.
The Journal of Biological Chemistry
|
April 2, 2011
Focal adhesion kinase (FAK) binds RET kinase via its FERM domain, priming a direct and reciprocal RET-FAK transactivation mechanism
Iván Plaza-Menacho, Andrea Morandi, Luca Mologni, et al.
Cancer Research
|
January 23, 2016
miR-155 Drives Metabolic Reprogramming of ER+ Breast Cancer Cells Following Long-Term Estrogen Deprivation and Predicts Clinical Response to Aromatase Inhibitors
Marina Bacci, Elisa Giannoni, Antony Fearns, et al.
Page
of 7